Pharming Group N.V. Current Value Added Tax Receivables
Pharming Group N.V. (PHAR) had Current Value Added Tax Receivables of $2.18 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes › Receivables
ifrs-full:CurrentValueAddedTaxReceivables · last filed 2026-04-02
- 2020-12-31: Current Value Added Tax Receivables 1.32M EUR.
- 2019-12-31: Current Value Added Tax Receivables 1.19M EUR.
EUR
| Period end | Current Value Added Tax Receivables |
|---|---|
| 2020-12-31 | 1.32M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 1.19M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Current Value Added Tax Receivables |
|---|---|
| 2025-12-31 | $2.18M 20-F · filed 2026-04-02 |
| 2024-12-31 | $3.64M 20-F · filed 2026-04-02 |
| 2023-12-31 | $3.80M 20-F · filed 2025-04-03 |
| 2022-12-31 | $1.45M 20-F · filed 2024-04-04 |
| 2021-12-31 | $2.49M 20-F · filed 2023-04-05 |
| 2020-12-31 | $1.63M 20-F · filed 2022-04-06 |